• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celsion Corp (NQ: CLSN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.900 (5)
Ask (Size) 2.100 (31)
Prev. Close 1.960
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 14,400,889
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via Benzinga
Celsion Earnings Perspective: Return On Capital Employed
September 09, 2022
According to Benzinga Pro data, during Q2, Celsion (NASDAQ:CLSN) posted sales of $125 thousand. Earnings were up 42.31%, but Celsion still reported an overall loss of $6.04 million. 
Via Benzinga

Performance

More News

Read More
Recap: Celsion Q2 Earnings
August 15, 2022
Via Benzinga
Earnings Outlook For Celsion
August 12, 2022
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Via Benzinga
Celsion: Q1 Earnings Insights
May 16, 2022
Via Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Via Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Via Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
May 18, 2022
Via FinancialNewsMedia
Topics Death
Exposures Death
Earnings Outlook For Celsion
May 13, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Via Benzinga
Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
April 21, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 21, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
April 13, 2022
Via Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Via Benzinga
53 Biggest Movers From Yesterday
April 08, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 07, 2022
Via Benzinga
51 Biggest Movers From Yesterday
April 07, 2022
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down 5%; Celsion Shares Plummet
April 06, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Via Benzinga
Why Celsion Shares Are Pulling Back Today
April 06, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Via Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap